GT Biopharma (GTBP) Short Interest Ratio & Short Volume → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free GTBP Stock Alerts $3.75 -0.11 (-2.85%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends GT Biopharma Short Interest DataCurrent Short Interest2,700 sharesPrevious Short Interest6,000 sharesChange Vs. Previous Month-55.00%Dollar Volume Sold Short$8,235.00Short Interest Ratio0.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares1,420,000 sharesFloat Size1,270,000 sharesShort Percent of Float0.21%Today's Trading Volume17,655 sharesAverage Trading Volume831,573 sharesToday's Volume Vs. Average2% Short Selling GT Biopharma ? Sign up to receive the latest short interest report for GT Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGTBP Short Interest Over TimeGTBP Days to Cover Over TimeGTBP Percentage of Float Shorted Over Time Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. GT Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20242,700 shares $8,235.00 -55.0%0.2%0 $3.05 4/30/20246,000 shares $18,000.00 +81.8%0.5%0.5 $3.00 4/15/20243,300 shares $12,408.00 -62.5%0.3%0.3 $3.76 3/31/20248,800 shares $38,984.00 +79.6%0.7%0.7 $4.43 3/15/20244,900 shares $22,687.00 -14.0%0.4%0.4 $4.63 2/29/20245,700 shares $24,282.00 +72.7%0.5%0.6 $4.26 Get the Latest News and Ratings for GTBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/20243,300 shares $13,200.00 +312.5%0.3%0.4 $4.00 1/31/2024800 shares $4,752.00 -98.6%0.1%0.1 $5.94 1/15/202458,800 shares $13,171.20 +150.2%0.2%0.4 $0.22 12/31/202323,500 shares $5,992.50 -64.8%0.1%0.2 $0.26 12/15/202366,800 shares $16,472.88 +14.8%0.2%0.6 $0.25 11/30/202358,200 shares $12,804.00 -62.3%0.2%0.5 $0.22 11/15/2023154,300 shares $37,032.00 +16.1%0.4%1.2 $0.24 10/31/2023132,900 shares $33,278.16 -16.8%0.4%0.9 $0.25 10/15/2023159,800 shares $40,749.00 +56.4%0.4%1 $0.26 9/30/2023102,200 shares $24,640.42 +122.2%0.3%0.4 $0.24 9/15/202346,000 shares $12,880.00 -12.9%0.1%0.1 $0.28 8/31/202352,800 shares $13,780.80 -76.7%0.1%0.1 $0.26 8/15/2023227,000 shares $59,996.10 +22.3%0.6%0.4 $0.26 7/31/2023185,600 shares $51,040.00 -15.6%0.5%0.3 $0.28 7/15/2023219,900 shares $73,402.62 -1.7%0.6%0.4 $0.33 6/30/2023223,600 shares $69,763.20 +9.3%0.6%0.4 $0.31 6/15/2023204,600 shares $71,589.54 +53.5%0.6%0.5 $0.35 5/31/2023133,300 shares $30,019.16 -5.7%0.4%0.5 $0.23 5/15/2023141,400 shares $42,391.72 -12.8%0.4%0.9 $0.30 1/29/2021102,800 shares $47,550.14 +411.4%N/A0.1 $0.46 1/15/202127,100 shares $13,818.29 +118.6%N/A0 $0.51 12/31/202010,200 shares $4,386.00 -62.4%N/A0 $0.43 12/15/202027,100 shares $7,859.00 +118.6%N/A0 $0.29 11/30/202012,400 shares $2,168.76 -34.7%N/A0 $0.17 11/15/202019,000 shares $3,467.50 -54.2%N/A0 $0.18 10/30/202041,500 shares $8,590.50 +24.3%N/A0.1 $0.21 10/15/202033,400 shares $6,680.00 +59.8%N/A0 $0.20 9/30/202020,900 shares $3,657.50 +770.8%N/A0.1 $0.18 9/15/20202,400 shares $408.00 -81.5%N/A0 $0.17 8/31/202013,000 shares $2,382.90 +20.4%N/A0.1 $0.18 8/14/202010,800 shares $1,922.40 -26.5%N/A0 $0.18 7/31/202014,700 shares $2,940.00 -30.7%N/A0 $0.20 7/15/202021,200 shares $4,452.00 -0.5%N/A0.1 $0.21 6/30/202021,300 shares $2,982.00 -47.4%N/A0.1 $0.14Kiss of death from Joe Biden (Ad)In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. 6/15/202040,500 shares $8,505.00 +130.1%N/A0.3 $0.21 5/29/202017,600 shares $3,560.48 +175.0%N/A0.1 $0.20 5/15/20206,400 shares $1,312.00 -72.5%N/A0 $0.21 4/30/202023,300 shares $3,259.67 +870.8%N/A0.3 $0.14 4/15/20202,400 shares $360.00 -41.5%N/A0 $0.15 3/31/20204,100 shares $627.30 -93.6%N/A0 $0.15 3/13/202063,900 shares $11,502.00 +2,562.5%N/A0.1 $0.18 2/28/20202,400 shares $235.20 No ChangeN/A0 $0.10 2/14/20202,400 shares $228.72 -67.1%N/A0 $0.10 1/31/20207,300 shares $740.22 +204.2%N/A0 $0.10 1/15/20202,400 shares $240.00 -79.5%N/A0 $0.10 12/31/201911,700 shares $1,170.00 +9.4%N/A0 $0.10 GTBP Short Interest - Frequently Asked Questions What is GT Biopharma's current short interest? Short interest is the volume of GT Biopharma shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 2,700 shares of GTBP short. 0.21% of GT Biopharma's shares are currently sold short. Learn More on GT Biopharma's current short interest. What is a good short interest percentage for GT Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.21% of GT Biopharma's floating shares are currently sold short. Is GT Biopharma's short interest increasing or decreasing? GT Biopharma saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 2,700 shares, a decline of 55.0% from the previous total of 6,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is GT Biopharma's float size? GT Biopharma currently has issued a total of 1,420,000 shares. Some of GT Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GT Biopharma currently has a public float of 1,270,000 shares. How does GT Biopharma's short interest compare to its competitors? 0.21% of GT Biopharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to GT Biopharma: Purple Biotech Ltd (1.02%), Vincerx Pharma, Inc. (1.92%), MEI Pharma, Inc. (0.50%), Synlogic, Inc. (1.13%), Lumos Pharma, Inc. (5.74%), KALA BIO, Inc. (0.25%), Talphera, Inc. (0.72%), Orgenesis Inc. (0.72%), Alaunos Therapeutics, Inc. (10.54%), VBI Vaccines Inc. (1.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short GT Biopharma stock? Short selling GTBP is an investing strategy that aims to generate trading profit from GT Biopharma as its price is falling. GTBP shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GT Biopharma? A short squeeze for GT Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GTBP, which in turn drives the price of the stock up even further. How often is GT Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GTBP, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PPBT Short Interest Data VINC Short Interest Data MEIP Short Interest Data SYBX Short Interest Data LUMO Short Interest Data KALA Short Interest Data TLPH Short Interest Data ORGS Short Interest Data TCRT Short Interest Data VBIV Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GTBP) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders41 banks launch ‘crypto dollar’Stansberry ResearchShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeBill Clinton Backing Biden Replacement???The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.